We Are IU
Ozempic and similar GLP-1 drugs—with their quick weight-loss effects—have become ubiquitous topics in health care and popular culture. While this new frontier of pharmaceuticals became wildly popular in just a few years, the science took decades to develop. Much of the research and innovation have ties to Indiana University, and a key player is IU Distinguished Professor Richard DiMarchi. In this episode, DiMarchi discusses the trend of GLP-1s and his contributions to the research that made them possible.
12 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de We Are IU community!